These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6247830)
61. [Higher fatty acids of the blood in viral hepatitis B and subhepatic jaundice of tumor origin]. Levina LD; Zueva VV Klin Med (Mosk); 1985 May; 63(5):106-8. PubMed ID: 4046507 [No Abstract] [Full Text] [Related]
62. [Clinical significance of cyclic adenosine 3', 5'-monophosphate determination in chronic kidney failure]. Schneider W; Jutzler GA Med Welt; 1974 Jul; 25(29):1236-40. PubMed ID: 4368080 [No Abstract] [Full Text] [Related]
63. [Concentration of human ovarian adenosine-3'-5'-monophosphate during menstrual cycle and changes of its accumulation]. Miura S; Otani K; Kase Y Horumon To Rinsho; 1977 Apr; 25(4):449-54. PubMed ID: 194741 [No Abstract] [Full Text] [Related]
64. [Serum cyclic adenosine-3',5'-monophosphate in patients with viral hepatitis]. Pawlak J Pol Arch Med Wewn; 1977 Nov; 58(5):467-70. PubMed ID: 202931 [No Abstract] [Full Text] [Related]
65. [Determination of plasma cyclic adenosine-3',5-monophosphate during the cycle, pregnancy and menopause]. Oertel GW; Scheben U; Schirazi M; Hoffmann G Arch Gynakol; 1975 Nov; 219(1-4):602-3. PubMed ID: 174512 [No Abstract] [Full Text] [Related]
66. [Evaluation of changes of plasma cyclic AMP level in obstructive jaundice]. Kondoh M Nihon Shokakibyo Gakkai Zasshi; 1983 Jan; 80(1):76-84. PubMed ID: 6302354 [No Abstract] [Full Text] [Related]
67. [Blood bactericidal system in experimental cholacidemia]. Andreĭchin MA; Sytnik IA Zh Mikrobiol Epidemiol Immunobiol; 1979 Nov; (11):102-4. PubMed ID: 516948 [No Abstract] [Full Text] [Related]
68. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease. Klotz U; Antonin KH Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401 [TBL] [Abstract][Full Text] [Related]
69. Glucagon stimulated plasma cyclic adenosine-3',5'-monophosphate in the differential diagnosis of jaundice. Carstensen HE; Bruun E; Hansen OH; Marcussen H; Mollerup C Surg Gynecol Obstet; 1979 Oct; 149(4):503-5. PubMed ID: 225837 [TBL] [Abstract][Full Text] [Related]
70. [Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis]. Calvo C; Arroqui I Rev Med Chil; 1984 Mar; 112(3):233-7. PubMed ID: 6473964 [No Abstract] [Full Text] [Related]
71. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)]. Jäckel W; Heimes J; Herrmann J J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272 [TBL] [Abstract][Full Text] [Related]
72. [Lipoprotein-X as an indicator of cholestasis in liver and biliary tract diseases]. Sawaryn T Wiad Lek; 1984 Oct; 37(19):1522-7. PubMed ID: 6396957 [No Abstract] [Full Text] [Related]
73. [The effect of glucagon on plasma adenosine cyclic-3'-5'-monophosphate in intrahepatic and extrahepatic cholestases]. Malinovská V; Rysánek K; Bílková B; Jahodová D Vnitr Lek; 1980 Apr; 26(4):229-33. PubMed ID: 6247830 [No Abstract] [Full Text] [Related]